IDO1 Is a Therapeutic Target for Pancreatic Cancer–Associated Depression | Citedby Results | Molecular Cancer Therapeutics | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

IDO1 Is a Therapeutic Target for Pancreatic Cancer–Associated Depression

Mol Cancer Ther (2022) 21 (12): 1810–1822.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease

M. V. Kozhevnikova
A. V. Krivova
E. O. Korobkova
A. A. Ageev
K. M. Shestakova
N. E. Moskaleva
S. A. Appolonova
E. V. Privalova
Yu. N. Belenkov

Kardiologiia (2022) 62 (11): 40.

Synergistic Effects of the Combinational Use of Escitalopram Oxalate and 5-Fluorouracil on the Inhibition of Gastric Cancer SNU-1 Cells

Vincent Chin-Hung Chen
Jing-Yu Huang
Bor-Show Tzang
Tsai-Ching Hsu
Roger S. McIntyre

International Journal of Molecular Sciences (2022) 23 (24): 16179.